“…Several bacterial and fungus endoglycosidases, including Endo-A, Endo-M, Endo-D, Endo-S, and Endo-F3, which possess distinct glycan and acceptor substrate specificity, have been converted into glycosynthases for synthetic applications (Wang and Lomino, 2012). These enzymes have been used for the synthesis of large and complex glycopeptides including HIV-1 glycopeptide antigens (Amin et al, 2013; Huang et al, 2009a; Huang et al, 2010b; Li et al, 2005a; Li et al, 2005b); for glycosylation remodeling to produce homogeneous glycoproteins carrying natural and selectively modified (e.g., azide-tagged or fluorinated) N-glycans (Amin et al, 2011; Huang et al, 2009b; Huang et al, 2010a; Li et al, 2006; Ochiai et al, 2008; Orwenyo et al, 2013; Schwarz et al, 2010; Umekawa et al, 2010); and for glycoengineering of intact IgG antibodies (Fan et al, 2012; Huang et al, 2012; Wei et al, 2008; Zou et al, 2011). This chemoenzymatic method was also successfully combined with NCL for synthesizing full-size glycosylated proteins (Asahina et al, 2013; Hojo et al, 2012).…”